Genotyping of the prevalent Chlamydia trachomatis strains involved in cervical infections in women in Ahvaz, Iran

Journal of Medical Microbiology - Tập 59 Số 9 - Trang 1023-1028 - 2010
Behrouz Taheri Beni1, Hossein Motamedi1, Mohammad Roayaei Ardakani‬1
1Department of Biology, Faculty of Science, Shahid Chamran University, Ahvaz, Iran

Tóm tắt

To determine the prevalence of cervicalChlamydia trachomatisgenotypes in Iran for the first time and their association with three clinical symptoms/signs, i.e. abnormal vaginal discharge, lower abdominal pain (LAP) and swab-induced bleeding, and patient age, 620 cervical specimens were obtained from women with symptomatic genital infection referred to gynaecological clinics and 108C. trachomatis-positive specimens were genotyped by directomp1gene PCR-RFLP analysis. Eight genotypes were identified. The most prevalent genotype was E (31.5 %), followed by F (23.1 %), D/Da (13 %), K (9.2 %), I (8.3 %), G (7.5 %), H (5.5 %) and J (1.9 %). For analysing the association ofC. trachomatisgenotypes with symptoms/signs and age,P-values were separately evaluated for genogroups and genotypes. The analysis of genogroups showed that women infected with genogroup F/G manifested the symptom of LAP significantly more often than those infected with the other genogroups (P=0.02), while the analysis of genotypes revealed that women infected with genotype F reported LAP slightly more often than women infected with the other genotypes (P=0.08). No significant correlation between genogroups and age was found; however, genotype E was somewhat less prevalent among women aged 25–34 years than among other age groups (P=0.08).

Từ khóa


Tài liệu tham khảo

Bakhtiari, 2007, Chlamydia trachomatis infection in women attending health centres in Babol: prevalence and risk factors, East Mediterr Health J, 13, 1124, 10.26719/2007.13.5.1124

Barnes, 1987, Comparison of Chlamydia trachomatis serovars causing rectal and cervical infection, J Infect Dis, 156, 953, 10.1093/infdis/156.6.953

Chamani-Tabriz, 2007, Chlamydia trachomatis prevalence in Iranian women attending obstetrics and gynaecology clinics, Pak J Biol Sci, 10, 4490, 10.3923/pjbs.2007.4490.4494

Eckert, 2000, Quantitative Chlamydia trachomatis cultures: correlation of chlamydial inclusion-forming units with serovar, age, sex, and race, J Infect Dis, 182, 540, 10.1086/315738

Gao, 2007, Distribution study of Chlamydia trachomatis serovars among high-risk women in China performed using PCR-restriction fragment length polymorphism genotyping, J Clin Microbiol, 45, 1185, 10.1128/JCM.02076-06

Geisler, 2003, The relationship of serovars to clinical manifestation of urogenital Chlamydia trachomatis infection, Sex Transm Dis, 30, 160, 10.1097/00007435-200302000-00013

Ghanaat, 2008, Prevalence of genital Chlamydia in Iranian males with urethritis attending clinics in Mashhad, East Mediterr Health J, 14, 1333

Hashemi, 2007, Frequency of Chlamydia trachomatis in women with cervicitis in Tehran, Iran, Infect Dis Obstet Gynecol, 10.1155/2007/67014

Hsu, 2006, Genotyping of Chlamydia trachomatis from clinical specimens in Taiwan, J Med Microbiol, 55, 301, 10.1099/jmm.0.46262-0

Lan, 1993, Direct detection and genotyping of Chlamydia trachomatis in cervical scrapes by using polymerase chain reaction and restriction fragment length polymorphism analysis, J Clin Microbiol, 31, 1060, 10.1128/JCM.31.5.1060-1065.1993

Molano, 2005, The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study, J Infect Dis, 191, 907, 10.1086/428287

Morré, 1998, Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovars Ba, G, and J as confirmed by omp1 nucleotide sequence analysis, J Clin Microbiol, 36, 345, 10.1128/JCM.36.2.345-351.1998

Morré, 2000, Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations?, J Clin Microbiol, 38, 2292, 10.1128/JCM.38.6.2292-2296.2000

Nazer, 2008, Determination of asymptomatic Chlamydia trachomatis infections by omp1 gene based-PCR, Yakhteh Med J, 10, 41

Ngandjio, 2004, Restriction endonuclease patterns of the omp1 gene of reference Chlamydia trachomatis strains and characterization of isolates from Cameroonian students, J Med Microbiol, 53, 47, 10.1099/jmm.0.05333-0

Persson, 1993, Lack of evidence of a relationship between genital symptoms, cervicitis and salpingitis and different serovars of Chlamydia trachomatis, Eur J Clin Microbiol Infect Dis, 12, 195, 10.1007/BF01967111

Rodriguez, 1991, Typing of Chlamydia trachomatis by restriction endonuclease analysis of the amplified major outer membrane protein gene, J Clin Microbiol, 29, 1132, 10.1128/JCM.29.6.1132-1136.1991

Rodriguez, 1993, Evaluation of molecular typing for epidemiological study of Chlamydia trachomatis genital infections, J Clin Microbiol, 31, 2238, 10.1128/JCM.31.8.2238-2240.1993

Samarbaf-Zadeh, 2007, Prevalence of C. trachomatis infection among Ahvaz females with vaginal discharge, Iran J Fertil Steril, 1, 19

Sturm-Ramirez, 2000, Molecular epidemiology of genital Chlamydia trachomatis infection in high-risk women in Senegal, West Africa, J Clin Microbiol, 38, 138, 10.1128/JCM.38.1.138-145.2000

van de Laar, 1996, Differences in clinical manifestations of genital chlamydial infections related to serovars, Genitourin Med, 72, 261

van Duynhoven, 1998, Chlamydia trachomatis genotypes: correlation with clinical manifestations of infection and patients’ characteristics, Clin Infect Dis, 26, 314, 10.1086/516291

2001, Global prevalence and incidence of selected curable sexually transmitted infection: overview and estimates. WHO/HIV_AIDS/2001.02

Workowski, 1994, Clinical manifestation of genital infection due to Chlamydia trachomatis in women: differences related to serovars, Clin Infect Dis, 19, 756, 10.1093/clinids/19.4.756

Yuan, 1989, Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars, Infect Immun, 57, 1040, 10.1128/IAI.57.4.1040-1049.1989